Cleveland Clinic Florida

Hospital associated with this Participant

Cleveland Clinic Florida
Weston, FL

Performance for Lobectomy Compared to STS and National Outcomes*

* These NIS data are the most recent data available at this time. There are more lobectomy for lung cancer patients in a single year of NIS data than in the GTSD, so a decision was made to use 3 years of STS GTSD data.

Lobectomy for Lung Cancer Composite Measure Results

Year	Overall Composite Score	Absence of Mortality	Absence of Major Complication
January 2015 – December 2017	Overall Composite Rating 96.8%	Absence of Mortality Rating 98.6%	Absence of Morbidity Rating 89.6%

Discharge Mortality Percent

2.3%

Discharge Mortality Lower 95 CI

0.3%

Discharge Mortality Upper 95 CI

7.9%

STS Discharge Mortality Percent

0.8%

NIS Discharge Mortality Percent

1.4%

96.8%

Overall Composite Score

98.6%

Absence of Mortality Score

89.6%

Absence of Morbidity Score

NIS PLOS Median

4.90

PLOS Lower Quartile

3.00

PLOS Median

5.00

PLOS Upper Quartile

7.00

STS PLOS Median

4.00

Star rating definitions are based only on a comparison of STS General Thoracic Surgery Database participants:

One Star: Lower Than Expected Performance
Two Stars: As Expected Performance
Three Stars: Higher Than Expected Performance

Bayesian Credible Intervals: The Bayesian credible interval shows the range in which the participant’s true score is likely to lie. STS uses 95% credible intervals. Unlike traditional confidence intervals, the Bayesian credible interval has an intuitive probability interpretation. Based on the observed data it can be said that it is 95% likely that the true proportion falls within the upper and lower limits of the 95% credible interval.

Detailed information regarding the lobectomy for lung cancer composite measure is provided in the following manuscript:
Kozower BD, O’Brien SM, Kosinski A, Magee MJ, Dokholyan R, Jacobs JP, Shahian DM, Wright CD, Fernandez FG. The Society of Thoracic Surgeons composite score for rating program performance for lobectomy for lung cancer. Ann Thorac Surg. 2016; 101(4):1379-87. DOI: http://dx.doi.org/10.1016/j.athoracsur.2015.10.081